Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.

× No keyword cloud information.

44 in total

Review 1. Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging.

Authors: Gurusher Singh Panjrath; Diwakar Jain
Journal: J Nucl Cardiol Date: 2006 May-Jun Impact factor: 5.952

2. Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial study.

Authors: Ali Momeni; Ali Hajigholami; Shohreh Geshnizjani; Soleiman Kheiri
Journal: J Clin Diagn Res Date: 2015-04-01

Review 3. Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Authors: Erika Vacchelli; Norma Bloy; Fernando Aranda; Aitziber Buqué; Isabelle Cremer; Sandra Demaria; Alexander Eggermont; Silvia Chiara Formenti; Wolf Hervé Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal: Oncoimmunology Date: 2016-07-25 Impact factor: 8.110

Review 4. Amifostine in the management of radiation-induced and chemo-induced mucositis.

Authors: Rene-Jean Bensadoun; Mark M Schubert; Rajesh V Lalla; Dorothy Keefe
Journal: Support Care Cancer Date: 2006-04-04 Impact factor: 3.603

Review 5. Chemotherapy and cardiotoxicity.

Authors: Howard Broder; Roberta A Gottlieb; Norman E Lepor
Journal: Rev Cardiovasc Med Date: 2008 Impact factor: 2.930

Review 10. The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review.

Authors: S M Swain; P Vici
Journal: J Cancer Res Clin Oncol Date: 2003-10-17 Impact factor: 4.553

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.

Review 1. Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging.

2. Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial study.

Review 3. Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Review 4. Amifostine in the management of radiation-induced and chemo-induced mucositis.

Review 5. Chemotherapy and cardiotoxicity.

6. Anthracycline cardiotoxicity: from bench to bedside.

Review 7. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies.

Review 8. Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity.

9. Dexrazoxane for preventing anthracycline cardiotoxicity in children with solid tumors.

Review 10. The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review.